TY - JOUR
T1 - Tunable Structured Metal Oxides for Biocatalytic Therapeutics
AU - Yuan, Minjia
AU - Li, Qian
AU - Gao, Yang
AU - He, Chao
AU - Adli, Mohsen
AU - Wu, Changzhu
AU - Zhou, Hongju
AU - Luo, Xianglin
AU - Ma, Lang
AU - Cheng, Chong
N1 - Funding Information:
This work was financially supported by the National Natural Science Foundation of China (Nos. 52161145402, 52173133, 82071938, 51803134), the Sichuan Science and Technology Program (Nos. 2023YFH0008, 2023NSFSC1596, 2022YFH0088), the 1·3·5 Project for Disciplines of Excellence, West China Hospital, Sichuan University (No. ZYJC21047). Prof. Cheng acknowledges the financial support of the State Key Laboratory of Polymer Materials Engineering (Grant No. sklpme2021‐4‐02), and Fundamental Research Funds for the Central Universities.
Publisher Copyright:
© 2023 Wiley-VCH GmbH.
PY - 2023/10/2
Y1 - 2023/10/2
N2 - The past few decades have witnessed the flourish of creating metal oxides for biocatalytic therapeutics due to their structural diversities, feasible modifications, tunable catalytic sites, and low cost when compared to their natural enzyme counterparts. Here, in this timely review, the most recent progress and future trends in engineering tunable structured metal oxides and decoding their structure-reactivity relationships for biocatalytic therapeutics is comprehensively summarized. At first, the fundamental activities, evaluations, and mechanisms of metal oxide-based biocatalysts are carefully disclosed. Subsequently, the merits, design methods, and state-of-art achievements of different types of nanostructured and biofunctionalized metal oxides are thoroughly discussed. Thereafter, it provides detailed comments on the catalytic center modulation strategies to engineer metal oxides for efficient reactive oxygen species (ROS)-catalysis, including atomic catalytic site engineering, heterostructures, and support effects. Furthermore, the representative applications of these ROS-catalytic metal oxides have been systematically summarized, such as catalytic disinfections, cancer therapies, ROS scavenging and anti-inflammations, biocatalytic sensors, as well as corresponding toxicities. Finally, current challenges and future perspectives are also highlighted. It is believed that this review can provide cutting-edge and multidisciplinary instruction for the future design of ROS-catalytic metal oxides and stimulate their widespread utilization in broad therapeutic applications.
AB - The past few decades have witnessed the flourish of creating metal oxides for biocatalytic therapeutics due to their structural diversities, feasible modifications, tunable catalytic sites, and low cost when compared to their natural enzyme counterparts. Here, in this timely review, the most recent progress and future trends in engineering tunable structured metal oxides and decoding their structure-reactivity relationships for biocatalytic therapeutics is comprehensively summarized. At first, the fundamental activities, evaluations, and mechanisms of metal oxide-based biocatalysts are carefully disclosed. Subsequently, the merits, design methods, and state-of-art achievements of different types of nanostructured and biofunctionalized metal oxides are thoroughly discussed. Thereafter, it provides detailed comments on the catalytic center modulation strategies to engineer metal oxides for efficient reactive oxygen species (ROS)-catalysis, including atomic catalytic site engineering, heterostructures, and support effects. Furthermore, the representative applications of these ROS-catalytic metal oxides have been systematically summarized, such as catalytic disinfections, cancer therapies, ROS scavenging and anti-inflammations, biocatalytic sensors, as well as corresponding toxicities. Finally, current challenges and future perspectives are also highlighted. It is believed that this review can provide cutting-edge and multidisciplinary instruction for the future design of ROS-catalytic metal oxides and stimulate their widespread utilization in broad therapeutic applications.
KW - biocatalytic therapeutics
KW - biomedical applications
KW - metal oxide-based biocatalysis
KW - nanostructure engineering
KW - reactive oxygen species
U2 - 10.1002/adfm.202304271
DO - 10.1002/adfm.202304271
M3 - Journal article
AN - SCOPUS:85160774263
SN - 1616-301X
VL - 33
JO - Advanced Functional Materials
JF - Advanced Functional Materials
IS - 40
M1 - 2304271
ER -